Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026)
Vanda Pharmaceuticals (VNDA) posted Exchange Rate Effect of -$57000.0 for Q1 2026, down 385.0% sequentially from $20000.0 in Q4 2025, and down 216.33% YoY from $49000.0 in Q1 2025.
Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported Exchange Rate Effect for 10 years, with the latest figure at -$57000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 216.33% year-over-year to -$57000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83000.0 (up 17.0% YoY) and the FY2025 annual result came in at $23000.0, up 114.11% from the prior year.
- Exchange Rate Effect eased to -$57000.0 in Q1 2026 per VNDA's latest filing, from $20000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $183000.0 in Q4 2022 and troughed at -$202000.0 in Q4 2024.
- A 5-year average of $6764.7 and a median of $20000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 993.33% in 2025, down 364.71% in 2025.
- Over 5 years, Exchange Rate Effect stood at $183000.0 in 2022, then fell by 18.03% to $150000.0 in 2023, then plunged by 234.67% to -$202000.0 in 2024, then soared by 109.9% to $20000.0 in 2025, then tumbled by 385.0% to -$57000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$57000.0, $20000.0, and -$180000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | -36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36,000.00 |
| Jun 30, 2026 | -36,000.00 |
| Mar 31, 2026 | -57,000.00 |
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Sep 30, 2025 | -180,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 134,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Dec 31, 2024 | -202,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |